TQF3510 (semaglutide biosimilar)
/ Sino Biopharm
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 26, 2026
A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects
(clinicaltrials.gov)
- P3 | N=408 | Completed | Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Not yet recruiting ➔ Completed | Trial primary completion date: Jul 2026 ➔ Mar 2026
Trial completion • Trial primary completion date • Genetic Disorders • Obesity
1 to 1
Of
1
Go to page
1